Day: January 19, 2026

Perth, Jan. 19, 2026 (GLOBE NEWSWIRE) — BAGOÉ ACCIDENT UPDATE Perth, Western Australia/January 19, 2026/Perseus Mining Limited (ASX/TSX: PRU) regrets to advise that, following the announcement of a fatal offsite vehicle accident that occurred last Thursday January 15 near our Bagoé Gold Mine in Côte d’Ivoire, another occupant in that vehicle, also an employee of our contractor company Binkadi, who was receiving care in hospital, has passed away. The other passengers in the vehicle sustained minor injuries and have been released from hospital. We extend our deepest sympathies to Mr Vakaramoko Sangare’s family. Both Perseus and Binkadi are providing support to the family through this very difficult time. Perseus is also offering support to our entire team at the Sissingué complex as they come to terms with this tragic event. Perseus...

For the first time in history, EfTEN United Property Fund’s financial results in 2025 were based on a fully invested portfolio. The fund achieved historically highest profit, which increased by 2.2 times compared to 2024: EfTEN United Property Fund earned 3.57 million euros in net profit in 2025 (1.62 million euros in 2024), which constitutes 14% of the fund’s invested capital and approximately 17% of the fund’s market capitalization. The fund’s income increased from 1.82 million euros to 3.78 million euros in a year, and the fund’s distributions to investors exceeded 9% of the market capitalization in 2025. The fund’s results were supported primarily by the improved profitability of the Uus-Järveküla residential development and the investment to the Kristiine shopping centre, where the fund is invested through...

HONG KONG, Jan. 18, 2026 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Speed Liu as a Senior Managing Director in the Business Transformation practice in Asia within the firm’s Corporate Finance & Restructuring segment. Mr. Liu, who is based in Hong Kong, joins FTI Consulting with more than 20 years of experience in private equity driving growth strategies, turnaround plans and cost optimization initiatives. He has substantial expertise advising on buyout transactions, business transformation and transactions across the consumer, service and industrials sectors. In his role at FTI Consulting, Mr. Liu will support private equity and corporate clients in Asia and abroad with portfolio transformation, transactions, exit readiness and maximizing value creation. His appointment reinforces...

Approval Label May Include Opioid Reduction NEW YORK, Jan. 18, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided feedback received from the U.S. Food & Drug Administration (FDA) on potential filing of a Biologics License Application (BLA) for its allogeneic cell therapy product rexlemestrocel-L in patients with chronic discogenic low back pain (CLBP). This follows FDA’s Type B meeting review of data from Mesoblast’s first randomized controlled Phase 3 trial (MSB-DR003) on pain reduction and relationship to decreased use or elimination of opioids for up to three years following a single rexlemestrocel-L administration. Mesoblast is seeking FDA approval for rexlemestrocel-L based on reduction in CLBP through 12 months....